BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12798431)

  • 1. COX-2: an in vivo evidence of its participation in heat stress-induced myocardial preconditioning.
    Arnaud C; Joyeux-Faure M; Godin-Ribuot D; Ribuot C
    Cardiovasc Res; 2003 Jun; 58(3):582-8. PubMed ID: 12798431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits.
    Shinmura K; Tang XL; Wang Y; Xuan YT; Liu SQ; Takano H; Bhatnagar A; Bolli R
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10197-202. PubMed ID: 10963682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: role of cyclooxygenase-2.
    Tanaka K; Ludwig LM; Krolikowski JG; Alcindor D; Pratt PF; Kersten JR; Pagel PS; Warltier DC
    Anesthesiology; 2004 Mar; 100(3):525-31. PubMed ID: 15108964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. iNOS is a mediator of the heat stress-induced preconditioning against myocardial infarction in vivo in the rat.
    Arnaud C; Godin-Ribuot D; Bottari S; Peinnequin A; Joyeux M; Demenge P; Ribuot C
    Cardiovasc Res; 2003 Apr; 58(1):118-25. PubMed ID: 12667952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-1 mediates the final stage of morphine-induced delayed cardioprotection in concert with cyclooxygenase-2.
    Jiang X; Shi E; Nakajima Y; Sato S; Ohno K; Yue H
    J Am Coll Cardiol; 2005 May; 45(10):1707-15. PubMed ID: 15893191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COX-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts.
    Shinmura K; Nagai M; Tamaki K; Tani M; Bolli R
    Am J Physiol Heart Circ Physiol; 2002 Dec; 283(6):H2534-43. PubMed ID: 12388283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX-2 and iNOS in opioid-induced delayed cardioprotection in the intact rat.
    Patel HH; Hsu AK; Gross GJ
    Life Sci; 2004 May; 75(2):129-40. PubMed ID: 15120566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 mediates ischemic, anesthetic, and pharmacologic preconditioning in vivo.
    Alcindor D; Krolikowski JG; Pagel PS; Warltier DC; Kersten JR
    Anesthesiology; 2004 Mar; 100(3):547-54. PubMed ID: 15108967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COX-2 mediates morphine-induced delayed cardioprotection via an iNOS-dependent mechanism.
    Jiang X; Shi E; Nakajima Y; Sato S
    Life Sci; 2006 Apr; 78(22):2543-9. PubMed ID: 16325209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delta-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits.
    Kodani E; Xuan YT; Shinmura K; Takano H; Tang XL; Bolli R
    Am J Physiol Heart Circ Physiol; 2002 Nov; 283(5):H1943-57. PubMed ID: 12384473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning.
    Shinmura K; Xuan YT; Tang XL; Kodani E; Han H; Zhu Y; Bolli R
    Circ Res; 2002 Mar; 90(5):602-8. PubMed ID: 11909825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice.
    Guo Y; Bao W; Wu WJ; Shinmura K; Tang XL; Bolli R
    Basic Res Cardiol; 2000 Dec; 95(6):479-84. PubMed ID: 11192369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
    Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
    J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xenon induces late cardiac preconditioning in vivo: a role for cyclooxygenase 2?
    Weber NC; Frässdorf J; Ratajczak C; Grueber Y; Schlack W; Hollmann MW; Preckel B
    Anesth Analg; 2008 Dec; 107(6):1807-13. PubMed ID: 19020121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotection during the final stage of the late phase of ischemic preconditioning is mediated by neuronal NO synthase in concert with cyclooxygenase-2.
    Wang Y; Kodani E; Wang J; Zhang SX; Takano H; Tang XL; Bolli R
    Circ Res; 2004 Jul; 95(1):84-91. PubMed ID: 15166094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain.
    Madrigal JL; Moro MA; Lizasoain I; Lorenzo P; Fernández AP; Rodrigo J; Boscá L; Leza JC
    Neuropsychopharmacology; 2003 Sep; 28(9):1579-88. PubMed ID: 12784118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2-mediated mechanism in conscious rats.
    Sato H; Bolli R; Rokosh GD; Bi Q; Dai S; Shirk G; Tang XL
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2557-64. PubMed ID: 17704286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cyclooxygenase-2 inhibitor NS-398 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene.
    Nagayama M; Niwa K; Nagayama T; Ross ME; Iadecola C
    J Cereb Blood Flow Metab; 1999 Nov; 19(11):1213-9. PubMed ID: 10566967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning.
    Bolli R; Shinmura K; Tang XL; Kodani E; Xuan YT; Guo Y; Dawn B
    Cardiovasc Res; 2002 Aug; 55(3):506-19. PubMed ID: 12160947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.